NEOGENOMICS INC
Company Stats
- Market Cap
- $2.4B
- as of Sep 30, 2026
- Enterprise Value
- $2.5B
- Shares Outstanding
- 128.5M
- Free Float
- 95.9%
Income Statement
- Revenue
- $727.3M
- Operating Income
- -$115.9M
- Net Income
- -$108.0M
- EBITDA
- -$79.8M
- Non-cash Impairment
- $3.5M
- Revenue Growth, 3Y
- 12.6%
- FCF Margin, 3Y Avg
- -4.4%
- FCF Margin, Worst Year
- -5.2%
Cash Flow
- Free Cash Flow
- -$21.8M
- FCF Yield
- -0.9%
- Owner FCF Yield
- -2.7%
Balance Sheet
- Cash & Equivalents
- $159.6M
- Total Debt
- $345.0M
- Net Debt
- $185.4M
Returns & Capital
- SBC, 3Y Avg
- $33.1M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $727.3M | -$21.8M | -3.0% |
| FY2024 | $660.6M | -$34.0M | -5.2% |
| FY2023 | $591.6M | -$30.7M | -5.2% |
| FY2022 | $509.7M | -$96.9M | -19.0% |
| FY2021 | $484.3M | -$90.9M | -18.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 10, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Delta and PepsiCo lower earnings outlooks as revenue rises
Stronger demand supports expansion as pricing diverges